Experienced senior level scientist with 10+ years of industry experience in translational sciences, in vivo pharmacology, and in vitro mechanism of action studies at top tier industry institutions. Expertise in areas of oncology, immune-oncology, metabolic disease, fibrosis, and autoimmune diseases. Proven track record of publication, posters, patents and IND enabling studies contributing for programs in including phase II and phase III clinical trials. Currently Pharmacology Group Lead Senior Scientist, Sardona Therapeutics, where we are using novel small molecules to target RNA-binding proteins and associated pathway dysregulation for oncology indications. Currently overseeing all in vivo pharmacology activities and in vitro support assays including efficacy, PK/PD establishment, mechanism of action studies, biomarker discovery and clinical patient population stratification efforts. Thrive in a highly dynamic fast paced environment to ensure delivery high impacts decision making results. ---Contact InformationeMail: dkellar13@gmail.comLnkIn: linkedin.com/in/danielle-kellar-3ba1a230